Taha Diman, Drop Joppe G, Wildschut Enno D, De Hoog Matthijs, van Ommen C Heleen, Reis Miranda Dinis Dos
Department of Adult Intensive Care, Erasmus Medical Center, Rotterdam, the Netherlands.
Department of Pediatric Hematology, Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, The Netherlands.
Perfusion. 2025 Apr;40(3):557-567. doi: 10.1177/02676591241253474. Epub 2024 May 13.
IntroductionBleeding and thrombotic complications are common in extracorporeal membrane oxygenation (ECMO) patients and are associated with increased mortality and morbidity. The optimal anticoagulation monitoring protocol in these patients is unknown. This study aims to compare the incidence of thrombotic and hemorrhagic complications before and after a protocol change. In addition, the association between hemostatic complications, coagulation tests and risk factors is evaluated.MethodsThis is a retrospective single center cohort study of adult ECMO patients. We collected demographics, ECMO parameters and coagulation test results. Outcomes of the aPTT guided and multimodal protocol, including aPTT, anti-Xa assay and rotational thromboelastometry were compared and the association between coagulation tests, risk factors and hemostatic complications was determined using a logistic regression analysis for repeated measurements.ResultsIn total, 250 patients were included, 138 in the aPTT protocol and 112 in the multimodal protocol. The incidence of thrombosis (aPTT: 14%; multimodal: 12%) and bleeding (aPTT: 36%; multimodal: 40%), did not significantly differ between protocols. In the aPTT guided protocol, the aPTT was associated with thrombosis (Odds Ratio [OR] 1.015; 95% confidence interval [CI] 1.004-1.027). In both protocols, surgical interventions were risk factors for bleeding and thrombotic complications (aPTT: OR 93.2, CI 39.9-217.6; multimodal OR 17.5, CI 6.5-46.9).DiscussionThe incidence of hemostatic complications was similar between both protocols and surgical interventions were a risk factor for hemostatic complications. Results from this study help to elucidate the role of coagulation tests and risk factors in predicting hemostatic complications in patients undergoing ECMO support.
引言
出血和血栓形成并发症在体外膜肺氧合(ECMO)患者中很常见,且与死亡率和发病率增加相关。这些患者的最佳抗凝监测方案尚不清楚。本研究旨在比较方案改变前后血栓形成和出血并发症的发生率。此外,还评估了止血并发症、凝血试验和危险因素之间的关联。
方法
这是一项针对成年ECMO患者的回顾性单中心队列研究。我们收集了人口统计学资料、ECMO参数和凝血试验结果。比较了活化部分凝血活酶时间(aPTT)指导方案和多模式方案的结果,包括aPTT、抗Xa测定和旋转血栓弹力图,并使用重复测量的逻辑回归分析确定凝血试验、危险因素和止血并发症之间的关联。
结果
总共纳入了250例患者,138例采用aPTT方案,112例采用多模式方案。两种方案之间血栓形成(aPTT方案:14%;多模式方案:12%)和出血(aPTT方案:36%;多模式方案:40%)的发生率无显著差异。在aPTT指导方案中,aPTT与血栓形成相关(比值比[OR]1.015;95%置信区间[CI]1.004 - 1.027)。在两种方案中,手术干预都是出血和血栓形成并发症的危险因素(aPTT方案:OR 93.2,CI 39.9 - 217.6;多模式方案OR 17.5,CI 6.5 - 46.9)。
讨论
两种方案的止血并发症发生率相似,手术干预是止血并发症的危险因素。本研究结果有助于阐明凝血试验和危险因素在预测接受ECMO支持患者的止血并发症中的作用。